title: Own experience in treatment of patients with penile cancer using photodynamic therapy.
abstract: Penile cancer is a rare pathology. For penile cancer surgical treatment, radiotherapy, chemotherapy, and combined modality treatment are available. Because of great importance of this organ for mental condition of patient, the development of organ-preserving methods allowing to minimize impact on patient's quality of life without compromising of oncological results is desirable. In the Center of Laser and Photodynamic diagnosis and treatment of tumors in P.A. Herzen Moscow Cancer Research Institute the methods of photodynamic therapy in patients with penile cancer have been developed. From 2011 to 2013 the treatment was conducted in 11 patients with precancer and cancer of penile. The average age was 56.6. According to morphological diagnosis photodynamic therapy (PDT) was performed using two methods. One method included topical application of agent for PDT and the second intravenous administration of photosensitizer. For topical application alasens was used and for intravenous injection we applied radachlorine. All patients had no complications. Complete regression was achieved in 9 patients, and partial regression in 2. Thus, the results showed that photodynamic therapy for penile cancer stage Tis-1N0M0 permits performing organ-preserving treatment with satisfactory oncological results and no impairment of patient's quality of life.
authors.affiliation: P.A. Herzen Moscow Cancer Research Institute, 2nd Botkinskiy Proezd 3, Moscow 125284, Russia.
authors.forename: Elena
authors.initials: E
authors.lastname: Filonenko
authors.affiliation: P.A. Herzen Moscow Cancer Research Institute, 2nd Botkinskiy Proezd 3, Moscow 125284, Russia.
authors.forename: Andrey
authors.initials: A
authors.lastname: Kaprin
authors.affiliation: P.A. Herzen Moscow Cancer Research Institute, 2nd Botkinskiy Proezd 3, Moscow 125284, Russia.
authors.forename: Boris
authors.initials: B
authors.lastname: Alekseev
authors.affiliation: P.A. Herzen Moscow Cancer Research Institute, 2nd Botkinskiy Proezd 3, Moscow 125284, Russia.
authors.forename: Antonina
authors.initials: A
authors.lastname: Urlova
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D007834:Lasers; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010412:Penile Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D017319:Photosensitizing Agents
references.citation: World J Urol. 2009 Apr;27(2):141-50
references.pmid: 18607597
references.citation: BJU Int. 2014 Dec;114(6):799-805
references.pmid: 24053403
references.citation: Ann Oncol. 2013 May;24(5):1179-89
references.pmid: 23293117
references.citation: Ther Adv Urol. 2013 Jun;5(3):161-9
references.pmid: 23730331